Company ProfilePremium

Australian Dairy Nutritionals Group

Company Profile Analysis

Ticker: AHF.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Australian Dairy Nutritionals Group - Company showcase

Year Founded & Workforce

1992

Australian Dairy Nutritionals Group logo

Australian Dairy Nutritionals Group Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Australian Dairy Nutritionals Group Overview

Australian Dairy Nutritionals is a vertically integrated, sub-scale producer of organic and organic A2-protein dairy nutritional powders, based in Camperdown in south-west Victoria's dairy "Golden Triangle". It owns one certified-organic A2 dairy farm (Yaringa, Nirranda South) and a small-run infant-formula base-powder plant at Depot Road, Camperdown. After a decade of pivots — from farm aggregator, to fresh-milk processor, to domestic infant-formula brand owner — the group now concentrates almost all its resources on one bet: building its Future™ infant-formula brand in China's mother-and-baby-store channel through an app-based online-to-offline platform. Contract packing for third parties and exports to Vietnam fill the rest of the plant. In FY26 nutritional powders were about 70% of customer revenue. Losses roughly halved to A$2.79M. However, cash was only A$1.16M at year-end, there is a A$1.5M secured loan due in about May 2027, and the auditor flagged a material uncertainty over going concern. Funding risk dominates the investment case.


Company's own description (FY26 Annual Report)

In its FY26 Annual Report, the company describes itself as a vertically integrated Australian dairy group. It says it owns high-quality organic and organic A2-protein dairy farms and a processing facility in south-west Victoria, and that it makes organic A2-protein infant formula from farm-fresh milk from its own farms. The FY26 Directors' Report lists four principal activities:

  1. Manufacturing nutritional base powders at 160 Depot Road, Camperdown.

  2. Distributing the group's nutritional-powder ranges through Organic Nutritionals Pty Ltd.

  3. Owning a dairy farm through Regen Properties Pty Ltd.

  4. Operating a dairy farm and owning livestock through SW Dairy Farms Pty Ltd.

Management says the strategy uses three assets: vertical integration, small-run manufacturing, and brand-building capability.

Independent characterisation

In substance, AHF is now an early-stage infant-formula brand owner and contract manufacturer with a farm attached. Its economics are determined by four things:

Volume through a fixed-cost plant: Utilisation drives the absorption of manufacturing overhead. The FY26 accounts explicitly credit higher manufactured volume for the improved segment result.

  • Consumer offtake of the Future™ brand in China, sold through distributor Mutree Science and Technology Limited via the AZ Global M2C ("mother-to-consumer") app into mother-and-baby stores.

Episodic contract-packing contracts: (Nutura from November 2024; Sprout from June 2025 to May 2026).

  • Market-access events, such as Vietnam's registration change, which halted exports from September 2025.

The farm is now a supporting asset. It supplies organic A2 milk for the plant, sells excess organic milk under contract, and acts as the collateral for the group's only secured borrowing.

Business and revenue model

Revenue streamModelFY26 revenue (AUD Mn)Share of customer revenue FY26Notes
Nutritional powders — own brand (Future™, China)Product sales to an exclusive distributor (Mutree)Included in 4.940Included in 69.9%Split between own brand and contract pack not disclosed
Nutritional powders — contract packing (Nutura, Sprout)Contract manufacturing (fee/product sale)Included in 4.940Included in 69.9%Sprout ended May 2026
Nutritional powders — Vietnam exportProduct sales to a distributor (Dunamex per FY24 Annual Report)Included in 4.940Included in 69.9%Suspended September 2025; resumption expected Q1 FY27
Dairy farms — raw organic milkCommodity sale under a farmgate contractIncluded in 2.127Included in 30.1%Contracted to 1 July 2027 at the FY26 price
Dairy farms — livestock salesSpot salesIncluded in 2.127Included in 30.1%Volume fell after herd reduction
Other (interest, rebates, recoveries)—0.087—Source: FY26 Annual Report, Note 3

The mix is 100% product revenue recognised at a point in time. There is no subscription, licensing or service revenue. A former Future-formula subscription model in Australia (FY22) was discontinued along with the Gradulac Gentle range in FY24.

Value-chain position, customers and end-markets

AHF spans the chain from pasture to base powder and branded product. It is not integrated into retail. Its customers are concentrated: two customers accounted for 89% of trade receivables at 30 June 2026 (five customers and 91% at 30 June 2025).

End-markets:

  • China infant milk formula (IMF), mother-and-baby-store/O2O channel

  • Vietnam IMF (distributor model)

  • Australian B2B contract manufacturing

  • Victorian organic farmgate milk

  • Cattle markets

Strategy

Stated strategy (FY26 Annual Report themes)

The FY26 report says the group is executing the strategic plan first set out in the FY24 Annual Report. The main themes, paraphrased:

  1. Grow nutritional powders aggressively, with resources focused on building the Future™ brand in China.

  2. Use contract packing (Nutura; formerly Sprout), Vietnam and Australia as extra volume for the plant.

  3. Use the group's vertical integration, small-run manufacturing and brand-building assets.

  4. For FY27 and beyond: sell and distribute the nutritional-powder ranges; make manufacturing more efficient; refine farming operations; manage non-operational costs.

Investor-day materials do not exist publicly.

Strategic initiatives (last 24 months)

InitiativeDateStatus / targets
Future™ brand China launch via the AZ Global M2C appShipments from March 2025Target of 1,000 outlets by FY26 achieved; 17 provinces; Mutree adding sales staff and expanding a sales-incentive plan in FY27
Exclusive Mutree supply agreement (5+5 years)September 2024First-year minimum of 100,000 units / A$2.5M
Contract-packing programmeNovember 2024 to presentNutura ongoing; Sprout ended May 2026; talks with other parties are continuing
Vietnam re-entrySuspended September 2025Resumption guided for Q1 FY27 under the new registration process
Brand awareness: CBME Shanghai (July 2026), Vietbaby expo (March 2026)2,026Aimed at signing new distributors and store owners
Farm portfolio reduction (Brucknell North lease exit)May 2025Completed; herd reduced to 657
Ocean Dairy joint-venture termination1 June 2026AHF now owns 100%; simplifies the Ocean Road Dairies brand position
Board renewal (Espie) and China leadership (Zhang as GM China)July 2026Adds operational and supply-chain expertise to the board
Cost controlFY25–FY26Corporate costs -13% in FY25, +2.5% in FY26 (CPI-level)
Capital projects (possible)OngoingAdditional dryer or high-speed canning line mentioned as possible projects; no committed spend

ESG commitments. No formal emissions or sustainability targets have been announced.

Management guidance and medium-term targets

  • Profitability to keep improving in FY27.

  • Positive net profit and cash flow not expected until FY28 (FY26 Annual Report).

  • Cash flows expected to improve over the medium term through wider distribution (Q4 FY26 4C).

  • No numerical revenue, margin or EBITDA targets have been published.

Products & Services

Nutritional Powders segment

CounterpartyStartEndScopeDisclosed value
NuturaFirst shipment November 2024OngoingContract packing of nutritional powders—
SproutFirst shipment June 2025Concluded May 2026 (12-month contract)Contract packing—

Future™ infant formula (China).

Description: The group's strategic brand, relaunched as a "differentiated premium" infant formula for China. First shipped in March 2025.

Specifications: Full formulation and stage specifications not publicly disclosed. Company materials position it within the organic and A2-protein proposition and the English-label segment.

Target customer and channel: Chinese parents buying through mother-and-baby stores, reached via the AZ Global M2C app (O2O model), with Mutree as exclusive distributor.

Distribution scale: Five provinces at FY25 year-end; more than 1,000 distribution points across 17 provinces by FY26 year-end.

Momentum: M2C sell-out units grew quarter-on-quarter by 136%, 70%, 80% and 39% across FY26, an average of about 81%.

Pricing: Not disclosed.

Commercial terms: The Mutree agreement requires at least 100,000 units in the first 12 months, worth at least A$2.5M.

  • Source: FY25 and FY26 Annual Reports.

Future Gradulac Gentle (discontinued).

Description: A three-step formula with increasing lactose levels, positioned as gentle on babies' digestion.

History: Made by an external contractor. Ranged in Chemist Warehouse from April 2022, also sold on a subscription basis, and through cross-border e-commerce in China via a distributor called GMH. An application was made for accelerated US FDA approval in 2022 (outcome not disclosed).

Exit: Discontinued in FY24 because of poor consumer sales. A$0.419M of stock was written down and A$0.245M of intangibles were impaired.

  • Source: FY22 and FY24 Annual Reports.

Ocean Road Dairies Organic A2 infant formula.

Description: A three-stage organic A2-protein range made at Depot Road using milk from the group's own farms.

History: Sold in Chemist Warehouse from November 2022 through the Ocean Dairy joint venture. Also sold on JD.co.hk as an entry point to China (FY24). Domestic offtake was below expectations.

Write-downs: Legacy 2023-dated stock and ingredients were written down by A$0.193M (FY24) and A$0.753M (FY25).

Status: The joint venture ended on 1 June 2026, giving AHF full ownership of the vehicle. The brand is still cited in company boilerplate, but its active commercial status is not disclosed.

Organic A2 whole milk powder and base powders. Base powders made at Depot Road (organic and A2) feed both the group's own brands and contract customers. Plant capacity and run sizes are not disclosed. The company describes the facility as suited to "small run size" manufacturing.

Contract packing services.

Vietnam export range. Infant formula sold through distributor Dunamex. Launched in Q3 FY24. Second-half FY25 sales were more than five times the first half. Suspended from September 2025, with some stock returned, after Vietnam changed its registration and packaging rules. Management expects resumption in Q1 FY27.

Dairy Farms segment

ProductDescriptionFY26 metric
Organic A2 raw milkExcess milk from Yaringa sold under contract2.3ML produced (3.5ML FY25; 5.8ML FY24)
Dairy livestockSales of surplus cattle394 head sold (1,225 FY25)
HerdClosing herd numbers657 (766 FY25; 1,674 FY24)
Cows milkedAverage299 (569 FY25; 939 FY24)

The FY25 farmgate contract included an 11% price increase for 24 months from 1 July 2025. The FY26 Annual Report says excess organic milk is contracted until 1 July 2027 at the FY26 price.

Discontinued and legacy brands

The group previously made or sold these brands, all exited between FY21 and FY23:

Camperdown Dairy: fresh milk, cream and yoghurt; brand retained.

Jonesy's Dairy Fresh: distribution moved to Sealane Group in May 2021.

The Collective: yoghurt made under contract; ended April 2022.

Ecklin South: brand.

Victorian Farmers Direct: home delivery; sold April 2023.

Financial Narrative

Basis. FY2022–FY2026 audited consolidated statements. FY22 figures include the fresh-dairy processing business and are not comparable with later years. FY23 figures are continuing operations unless stated; the FY23 statutory loss including discontinued operations was A$9.394M. AHF does not report gross profit or EBITDA, so those lines are derived (EBITDA = loss before tax + finance costs + depreciation and amortisation).

Income statement

Notes:

  • FY22 EBITDA of -A$3.02M matches the company's reported operating EBITDA.

  • FY22 net loss includes a A$1.555M gain on the sale of Ecklin South.

  • FY24 EPS was restated to -1.13c in the FY25 report.

  • Income tax expense is nil in every year because of losses.

  • The FY25 Chair/CEO letter calls the A$5.26M result an "EBIT loss". It is actually the net loss; derived EBIT is -A$5.14M.

Margins (derived, % of revenue)

Gross profit. Not reported at group level, because expenses are presented by nature. A proxy for nutritional powders is revenue less cost of goods sold, before manufacturing overheads:

Revenue growth. Revenue CAGR FY22–FY26 was -17.0%, distorted by the exit from fresh dairy. On a continuing basis, FY23–FY26 CAGR was +6.9%. FY26 revenue was flat year-on-year (-0.2%); total revenue and other income rose 4%.

Balance sheet

Notes:

  • FY22 working capital includes A$6.425M of Brucknell North held for sale.

  • FY22 accumulated losses are the company's only, excluding the Trust's A$6.85M (shown in non-controlling interests).

  • The FY26 report gives FY25 NTA per share as 3.1c.

  • There is no goodwill. Intangibles are recipes, formulations and trademarks (cost A$0.630M), reclassified in FY26 from indefinite-life to a 10-year finite life.

Cash flow

FY23 operating cash flow includes -A$1.223M from discontinued operations. The FY24 cancellation and buy-back of 7M LTIP loan securities was not a market buyback.

Ratios (derived)

Not meaningful: net debt/EBITDA and interest coverage (EBITDA and EBIT are negative in all years). The cash conversion cycle cannot be computed because group-level COGS is not reported.

Quarterly trajectory, FY26 (Appendix 4C data)

Q1 nutritional powders and Q3 cash/operating cash flow are derived approximations: Q1 NP is not stated in the summaries viewed (Q1 NP growth was +1,239% year-on-year); Q3 operating cash flow is implied from the full-year total; Q3 closing cash is a rough estimate. Treat these cells as indicative only.

Commentary on trends, inflections and drivers

Revenue. Reported revenue fell by more than half between FY22 and FY23 as the group deliberately shut fresh processing (about A$4M of annual revenue) and sold farms. Since then, revenue has been stuck at A$5.9–7.2M because farm revenue has been falling while nutritional powders grow. FY26 is the inflection year: nutritional powders (A$4.94M) are now larger than farm revenue had been in any year since FY24. Further growth no longer has a shrinking farm segment to offset.

Losses. The net loss halved twice: from A$7.44M in FY24 to A$5.26M in FY25, and to A$2.79M in FY26. The drivers were:

  • smaller inventory write-downs (A$0.75M in FY25 to A$0.14M in FY26);

  • a smaller herd, which cut feed and dairy-shed costs (dairy farm costs fell from A$4.14M in FY24 to A$2.17M in FY26);

  • better absorption of manufacturing overhead;

  • non-cash livestock fair-value gains (A$0.76M in FY26).

Corporate costs rose only 2% in FY26. Management guides that profitability will improve in FY27 but that positive net profit and cash flow are not expected until FY28.

Cash. Lower accounting losses have not translated into lower cash burn. Operating outflows were A$3.79M in FY26, higher than A$3.28M in FY25, because inventory rose by A$1.35M (raw materials and finished goods doubled to A$2.32M) to support Chinese distribution. Over five years the group has funded about A$27M of cumulative negative free cash flow through farm sales (about A$26M of proceeds from FY22 to FY24) and equity (A$8.1M). The farm-sale route is now almost exhausted: only Yaringa (carrying value A$8.2M) and the Depot Road plant (A$4.7M) remain, and Yaringa is pledged to RELI Capital.

Balance sheet. Equity has fallen from A$39.9M to A$21.7M in four years. NTA per share has fallen from 7.2c to 2.7c. FY26 was the first year of net debt (A$0.46M) since the group became debt-free. Unrecognised tax assets of A$14.3M (tax-effected) are a hidden asset, but the company warns that its ability to use the losses is uncertain under the continuity-of-ownership and same-business tests.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleOwnership

Australian Dairy Nutritionals Limited

Listed parent, head of the tax-consolidated group

Listed

Organic Nutritionals Pty Ltd

Distributes the nutritional-powder ranges

100%

Regen Properties Pty Ltd

Owns the Yaringa farm land; borrower under the RELI facility

100%

SW Dairy Farms Pty Ltd

Operates the farm; owns livestock

100%

Ocean Dairy Pty Ltd

Former Ocean Road Dairies joint venture with Wellnex Life

50% until 1 June 2026, then 100%

Camperdown Dairy Company Pty Ltd

Former fresh-milk processor; brand retained

Status not confirmed in FY26 materials

Revenue by Segment

SegmentFY2023FY2024FY2025FY2026

Nutritional Powders revenue & other income (AUD Mn)

0.4130.6683.0725.096

Dairy Farms revenue & other income (AUD Mn)

5.4425.5954.6912.996

Total segment revenue & other income (AUD Mn)

5.8566.2637.7638.093

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment by Service Line

Service lineFY2023FY2024FY2025FY2026

Nutritional powders (AUD Mn)

0.4070.6413.0724.940

Dairy farms (AUD Mn)

5.3975.5343.9622.127

Results by Segment

Segment resultFY2023FY2024FY2025FY2026

Nutritional Powders net result (AUD Mn)

-3.860-3.704-3.041-1.301

Dairy Farms net result (AUD Mn)

-0.724-1.929-0.6520.113

Corporate costs (AUD Mn)

-2.505-1.806-1.568-1.606

Segment expenses

Segment expensesFY2023FY2024FY2025FY2026

Nutritional Powders expenses (AUD Mn)

4.2734.3736.1136.397

Dairy Farms expenses (AUD Mn)

6.1667.5245.3432.883

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2024FY2025FY2026

Nutritional Powders YoY revenue growth (%)

61.7359.965.9

Dairy Farms YoY revenue growth (%)

2.8-16.2-36.1

Nutritional Powders net margin (%)

-554.6-99.0-25.5

Dairy Farms net margin (%)

-34.5-13.93.8

Nutritional Powders share of segment revenue (%)

10.739.663.0

Nutritional Powders share of customer revenue (%)

10.443.769.9

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

15.0635.8566.2637.1687.154

Other income (AUD Mn)

2.8980.0000.0000.5950.939

Depreciation & amortisation (AUD Mn)

0.9950.7531.0480.8610.548

Finance costs (AUD Mn)

0.1320.0570.1360.1170.056

EBITDA derived (AUD Mn)

-3.021-6.279-6.255-4.283-2.190

EBIT derived (AUD Mn)

-4.016-7.032-7.303-5.144-2.738

Loss before tax continuing (AUD Mn)

-4.149-7.088-7.439-5.261-2.794

Net loss total (AUD Mn)

-4.149-9.394-7.439-5.261-2.794

Net loss attributable to members (AUD Mn)

-4.148-9.329-7.356-5.209-2.842

Basic EPS (AUD cents)

-0.81-1.68-1.14-0.72-0.37

Diluted EPS (AUD cents)

-0.81-1.68-1.14-0.72-0.37

Dividends per share (AUD cents)

00000

Margin

MarginFY2022FY2023FY2024FY2025FY2026

EBITDA margin (%)

-20.1-107.2-99.9-59.7-30.6

EBIT margin (%)

-26.7-120.1-116.6-71.8-38.3

Net margin continuing (%)

-27.5-121.0-118.8-73.4-39.1

Income Statement and Margin Analysis (%)

Nutritional powders proxyFY2024FY2025FY2026

NP revenue less COGS (AUD Mn)

0.1800.7671.259

NP COGS gross margin proxy (%)

28.125.025.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Cash & equivalents (AUD Mn)

2.4322.0076.1062.6881.157

Trade & other receivables (AUD Mn)

0.9740.6600.5981.2611.441

Inventories (AUD Mn)

1.3991.5071.6241.3402.733

Biological assets (AUD Mn)

4.4163.7611.8741.0551.471

Property plant & equipment (AUD Mn)

27.00326.38218.85218.16217.643

Goodwill & intangibles (AUD Mn)

0.5470.6360.3940.3830.383

Total assets (AUD Mn)

44.60336.24030.34725.08925.219

Borrowings short-term (AUD Mn)

0.5030.0001.7400.0001.470

Borrowings long-term (AUD Mn)

0.0000.0000.0000.0000.000

Lease liabilities current (AUD Mn)

0.2430.5560.4640.0480.055

Lease liabilities non-current (AUD Mn)

0.3460.4850.0480.0000.096

Total debt incl leases (AUD Mn)

1.0911.0412.2530.0481.620

Net debt (AUD Mn)

-1.341-0.966-3.853-2.6400.463

Total liabilities (AUD Mn)

4.6542.7163.6201.4413.482

Total equity (AUD Mn)

39.94833.52326.72723.64721.737

Working capital (AUD Mn)

7.8532.4765.4004.1632.300

Accumulated losses (AUD Mn)

35.54249.05453.46358.67261.667

NTA per share (AUD cents)

7.25.44.13.22.7

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

-3.795-7.051-4.439-3.276-3.790

Capex PP&E (AUD Mn)

2.5760.8260.2490.1880.476

Capex intangibles (AUD Mn)

0.1420.1100.0320.0000.000

Free cash flow derived (AUD Mn)

-6.513-7.987-4.720-3.464-4.266

Asset sale proceeds (AUD Mn)

5.8867.1477.0160.1410.182

Net equity raised (AUD Mn)

2.7341.4340.6422.1221.166

Net secured borrowing (AUD Mn)

-5.9810.0001.676-1.7801.467

Dividends paid (AUD Mn)

00000

Buybacks (AUD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%)

-11.2-25.6-24.7-20.9-12.3

ROA (%)

-9.5-23.2-22.3-19.0-11.1

ROIC pre-tax (%)

-10.4-21.6-31.9-24.5-12.3

Current ratio (x)

2.862.132.523.921.68

Debt to equity (x)

0.030.030.080.000.07

Asset turnover (x)

0.340.140.190.260.28

Days sales outstanding (days)

23.641.234.964.273.5

Income Statement

MetricQ1FY26Q2FY26Q3FY26Q4FY26

Consolidated revenue (AUD Mn)

1.91.41.42.6

Nutritional powders revenue (AUD Mn)

1.00.7760.8802.1

Net operating cash flow (AUD Mn)

-0.655-1.11-0.625-1.4

Closing cash (AUD Mn)

1.90.8090.61.2

Geographies of Trade-receivable Credit Exposure by Year

YearGeographies of trade-receivable credit exposureInterpretation

FY2024

Australia only

Pre-China launch; Vietnam receivables not material at year-end

FY2025

Australia, Vietnam, Hong Kong

Hong Kong likely the invoicing point for China (Mutree); Vietnam active

FY2026

Australia, Hong Kong

Vietnam suspended from September 2025

Markets

MarketSegmentFY26 statusDirection

China (via Hong Kong / Mutree)

Nutritional Powders

Primary growth engine; 1,000+ outlets in 17 provinces

Fastest-growing

Australia (contract packing)

Nutritional Powders

Nutura ongoing; Sprout ended May 2026

Mixed / declining in FY27

Vietnam

Nutritional Powders

Suspended September 2025; resumption guided Q1 FY27

Declined sharply in FY26

Australia (Victoria farmgate and cattle)

Dairy Farms

Shrinking after lease exits

Declining

Share Price History

DatePrice (AUD)Context

March 2022

about 0.065

IJ Funds placement price

July 2023 / September 2024

0.022

Placement prices

March 2025

up to 0.056

Chair's on-market purchases

30 October 2025

0.038

Q1 FY26 4C release

21–22 January 2026

0.027–0.029

Q2 4C / trading halt

January–February 2026

0.028

Entitlement offer price

21 May 2026

0.022

RELI loan announcement

31 July 2026

0.017

Q4 FY26 4C

Latest

about 0.016

Recent quote

Share Count (M) and Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Weighted average shares (M)

511.5559.6650.4723.4768.0

Net equity raised (AUD Mn)

2.7341.4340.6422.1221.166

Dividends per share (AUD cents)

00000

Valuation Multiples

MultipleAHFBasis

Market capitalisation

about A$12.6M

about 787M shares

Enterprise value

about A$13.1M

Plus A$1.62M debt and leases, less A$1.16M cash

EV / Sales (FY26)

about 1.8x

Revenue A$7.15M

P / Book

about 0.58x

Equity A$21.74M

Price / NTA

about 0.59x

NTA 2.7c

Capital Instruments

InstrumentAmountMaturityTerms

RELI Capital secured loan (borrower Regen Properties; AHF guarantor)

A$1.5M (carrying value A$1.47M)

about 29 May 2027

9.74% variable, prepaid; establishment fee A$24,750; loan-to-value cap 40%; secured on Yaringa plus general security over the borrower's related assets

Lease liabilities

A$0.150M

A$0.055M current; A$0.096M non-current

Land lease

Unsecured short-term borrowings

Nil at year-end

Drawn and repaid within FY26 (A$0.327M)

Likely premium funding (nature not specified)

Analyst Conclusions

Management guidance

  • Profitability to improve further in FY27.

  • Positive net profit and cash flow not expected until FY28.

  • Vietnam shipments to resume in Q1 FY27.

  • Further distribution and provincial expansion in China during FY27.

  • The board is confident it can raise capital as needed.

No numerical guidance has been given. Consensus growth expectations are not publicly disclosed.

Bull case

  1. Operating leverage is visible. Nutritional-powder revenue rose 66% in FY26 while segment costs rose 5%, and the segment loss fell to A$1.30M. Another year of strong growth in Chinese offtake could bring the segment to break-even, especially with Vietnam returning.

  2. Strong downside asset cover. Farm and plant carrying values of about A$13M, plus total equity of A$21.7M, compare with a market capitalisation of about A$12.6M. The shares trade at about 0.6x NTA, and A$14.9M of unrecognised tax losses add optional value.

  3. People and channel fit. A chair with a proven a2 Milk Asia record (who keeps buying shares), a China GM with distribution experience, and an exclusive distributor that is expanding its sales force give the Future™ brand a credible route to scale in a fragmented A$25.5bn market where A2 is gaining share.

Bear case

  1. Funding is the main constraint. Cash of A$1.16M against annual operating burn of about A$3.8M, a A$1.5M loan due about May 2027, and an auditor's material uncertainty point to a near-term raising at depressed prices. The 2026 entitlement offer needed a shortfall placement, and further dilution is likely.

  2. Volume concentration and fragility. One China distributor, two customers holding 89% of receivables, the Sprout contract ended, and Vietnam suspended. Each FY26 quarter showed volatility: revenue swung between A$1.4M and A$2.6M.

  3. Execution history. Two earlier infant-formula brands (Future Gradulac Gentle; Ocean Road Dairies) failed commercially, producing about A$2.3M of inventory write-downs between FY23 and FY25. China's newborn decline and the dominance of large incumbents make sustained share gains hard for a brand with a A$0.37M marketing budget.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
By about 31 October 2026Q1 FY27 4C: evidence of Vietnam resumption; nutritional-powder revenue run-rate against Q4's A$2.1M; cash balance
About October–November 2026AGM: remuneration-report vote (a new strike cycle starts), any capital-raising authority
H2 CY2026New contract-packing agreement to replace Sprout (company has committed to disclose)
OngoingChina outlet count beyond 1,000; province expansion beyond 17; repeat-purchase metrics
February 2027H1 FY27 interim: segment break-even progress; going-concern language
By May 2027RELI loan refinancing or repayment; equity raise size and pricing
OngoingChina SAMR and Vietnam registration developments; Australian seasonal conditions and feed costs
OngoingInsider trading by the chair and directors (Appendix 3Y)

Analyst verdict

Australian Dairy Nutritionals has, after a decade of costly reinvention, arrived at a coherent and focused strategy. It is a small-run organic A2 nutritional-powder maker with its own milk supply and a single, measurable growth vector: the Future™ brand in China's mother-and-baby-store channel. FY26 delivered the clearest evidence yet that the model can work. Nutritional powders grew 66% to about 70% of customer revenue, the distribution target of 1,000 outlets was reached on schedule, quarterly sell-out compounded at about 81%, and the group loss fell 47% to A$2.79M with corporate costs held flat in real terms.

The equity story, however, is dominated by the balance sheet, not the income statement. Operating cash outflows actually rose in FY26 to A$3.79M as inventory was built for China. Year-end cash of A$1.16M covers roughly one quarter of burn. The group's only debt — a A$1.5M facility secured on the Yaringa farm — falls due in about May 2027. Management does not expect positive cash flow until FY28. The auditor's material-uncertainty paragraph is therefore a real constraint, not a formality. The most likely path is a further equity raising, or the monetisation of farm assets, before or around mid-2027. Both would dilute or shrink the asset backing that currently supports the share price at about 0.6x NTA.

For investors, AHF is a high-risk, binary micro-cap option on China execution. The bull case requires nutritional-powder revenue to keep growing at least 50% a year, Vietnam to return, a replacement contract-packing customer to be found, and funding on acceptable terms. The bear case needs only one more funding round at a discount. Our stance: speculative; monitor rather than accumulate until the Q1–Q2 FY27 quarterly reports show both continued revenue momentum and a credible funding solution. Asset backing limits, but does not remove, permanent capital-loss risk.


APPENDIX: SOURCES

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedBackgroundEducationShareholding

Peter Nathan

Executive Chairman

3 June 2024 (non-executive chair initially)

Former Asia Pacific CEO of the a2 Milk Company over a 14-year tenure, during which a2 revenue grew from A$7M to A$1.3bn per company bio; earlier sales and marketing roles at Colgate-Palmolive and Gillette; non-executive director of Comvita (NZX) since 20 July 2026

Bachelor of Business (Marketing), University of South Australia

15,073,518 shares; 3,000,000 options

Jason (Zhao Hui) Dong

Non-Executive Director

15 April 2021

Australia–China trade adviser; former adviser and research fellow at the Chinese Academy of Agricultural Sciences; former Alinta Energy board member; director of City Cable Australia

Master of Commerce (Melbourne); Bachelor of Economics (Shanxi University of Finance & Economics)

500,000 shares

Scott (Qing) Lai

Non-Executive Director

7 August 2023

Founder of IJ Financial Services (2017); director of IJ Funds Management, a major shareholder since 2022

Bachelor and Master of Commerce (Griffith)

49,064,135 shares

Daniel Espie

Independent Non-Executive Director

6 July 2026

28+ years in food, dairy (including infant formula), logistics and supply chain; senior roles at Fonterra, NewCold and IXOM

Bachelor of Technology and Postgraduate Diploma in Business (Massey)

Nil

Andy Zhang (former)

Non-Executive Director

2 October 2024 to 6 July 2026

Built a cross-border infant-formula distribution business to about A$400M of revenue; nominee of Alpha Professional Holdings; now General Manager – China

Master of Commerce, Professional Accounting (Deakin)

707,506 shares

Executive Leadership Team

NameTitleTenureNotes

Sundaranathan Mahinthan

Group CEO

Since 18 June 2024

Three-month notice period; prior career and education not disclosed in the annual reports reviewed

Peter Nathan

Executive Chairman

Since 2024

See above

Andy Zhang

General Manager – China

Since 6 July 2026

Moved from the board

Elizabeth Spooner

Company Secretary (outsourced, Confidant Partners)

Since 22 February 2024

Juris Doctor (ANU)

Directors' Remuneration

KMPSalary/feesAnnual leaveSuperShare-based paymentsTotal FY26Total FY25

Peter Nathan

100,125012,01514,725126,865122,839

Sundaranathan Mahinthan

331,54528,95530,00059,832450,332420,999

Scott Lai

65,00007,800072,80072,475

Jason Dong

60,00007,200067,20066,900

Andy Zhang

60,00007,200067,20049,995

Total

616,67028,95564,21574,557784,397733,208

Major Shareholders

HolderSharesApprox. %Source / basis

Scott Lai (relevant interest, linked to IJ Funds Management)

49,064,135

about 6.2% of about 787M

FY26 Annual Report

Miracle Plant Developments Limited

48,477,509

6.52% (of about 743M, January 2026)

S&P Global via Simply Wall St

Fire Dragon Capital Pty Ltd

Not stated

6.52% (January 2026)

S&P Global via Simply Wall St

Peter Nathan

15,073,518

about 1.9%

FY26 Annual Report

Sundaranathan Mahinthan

2,000,000

about 0.25%

FY26 Annual Report

Andy Zhang

707,506

about 0.1%

FY26 Annual Report

Jason Dong

500,000

about 0.06%

FY26 Annual Report

Competitive Landscape

Peer Comparison FY2026

MetricAHF (FY26)Bubs Australia (FY25)Noumi (H1 FY25)a2 Milk Co (FY25)

Revenue

A$7.15M

A$102.5M

A$299.3M (half-year)

—

Revenue growth

-0.2% (powders +66%)

+29%+2.6%—

Profitability

Net loss A$2.79M

Profit after tax A$5.5M

Net loss A$82.1M (including A$50M impairment); adjusted EBITDA A$27.5M

—

China revenue

—

A$21.1M (+22%)

Not applicable

Core market

Net margin

-39.1%

about 5.4%

Negative

Positive

“—” = not publicly disclosed.

Recent Developments

--

Company Snapshot

$4.6M

Revenue

1992

Founded

Camperdown, Australia

Headquarters

SWOT Analysis

Strengths

  • Fast-growing nutritional powders. Revenue up 66% in FY26 to A$5.10M, after +360% in FY25 (FY26 and FY25 Annual Reports).
  • Distribution target met on time. More than 1,000 China outlets across 17 provinces by June 2026, up from five provinces a year earlier (FY26 Annual Report).
  • Strong consumer pull-through. Average quarter-on-quarter sell-out growth of about 81% in FY26, with record repeat-purchase levels (FY26 Annual Report).
  • Losses cut sharply. Net loss down 47% to A$2.79M; down 62% from FY24's A$7.44M (FY24–FY26 Annual Reports).
  • Hard-asset backing. Yaringa farm (A$8.2M independent valuation, December 2025) and the Depot Road facility (A$4.74M) together exceed the market capitalisation of about A$12.6M. NTA is 2.7c per share against a price of about 1.6c (FY26 Annual Report).
  • Relevant leadership. The chair's a2 Milk Asia Pacific background, sustained insider buying (the chair added 4.73M shares in FY26), and a new director with Fonterra infant-formula operations experience (FY26 Annual Report).

Weaknesses

  • Thin liquidity. Cash of A$1.16M against FY26 operating cash burn of A$3.79M; auditor's material-uncertainty emphasis of matter (FY26 Appendix 4E).
  • Concentration. Two customers made up 89% of receivables (FY26 Note 6), with exclusive reliance on Mutree in China.
  • Track record of write-downs. Inventory write-downs of A$0.92M (FY23), A$0.61M (FY24) and A$0.75M (FY25) from failed or slow brands (Annual Reports).
  • Weak governance structure. No board committees; executive chair; two separate two-strike cycles (FY24 and FY26 Annual Reports).
  • Sub-scale. Revenue of A$7.15M supports corporate costs of A$1.61M (22% of revenue) (FY26 Annual Report).
  • Working-capital drag. Inventory doubled to A$2.73M and days sales outstanding rose to about 74 days (derived from the FY26 balance sheet).

Opportunities

  • Vietnam re-entry in Q1 FY27. Second-half FY25 Vietnam sales were five times the first half before the suspension (FY25 Annual Report).
  • New contract-packing customers to replace Sprout. Management says talks are continuing (FY26 Annual Report).
  • A2 segment tailwind. A2 protein is now 22% of China IMF value and still growing (Kantar, via the FY26 Annual Report).
  • Province expansion beyond 17 provinces, supported by Mutree's extra sales staff and incentives (FY26 Annual Report).
  • Tax losses. A$14.9M of tax-effected losses could shelter future profits if the continuity tests are met (FY26 Note 4).
  • Possible birth-rate support. Chinese policy focus and higher marriage numbers in 2025 (FY26 Annual Report).

Threats

  • Refinancing risk. The RELI A$1.5M loan matures about May 2027 (FY26 Annual Report).
  • Dilution. Equity was raised in each of the last five years at falling prices: 6.47c (2022), 2.2c (2023–24), 2.8c (2026) (Annual Reports).
  • Regulatory shocks. The Vietnam suspension shows exposure to sudden registration changes (FY26 Annual Report).
  • Demographics. China newborns fell 17.2% in 2025 (China National Bureau of Statistics, via the FY26 Annual Report).
  • Climate. Dry seasons pushed the farm to a A$0.37M operating loss in FY26 (FY26 Annual Report).
  • Incumbent competition. Large brands with much bigger marketing budgets, a risk the company itself flags (FY26 risk section).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Mar 2025 (context)First Future™ shipments to China; chair buys 980k shares at up to A$0.056 (4 March) and 595k (31 March)Strategy launch; insider confidence
Apr–May 2025Brucknell North leases terminated (229 acres on 15 April; 410 acres on 31 May)Farm revenue down, costs down
Jun 2025First Sprout contract-pack shipmentPlant utilisation
Jul 2025Q4 FY25 4C: Q4 infant-formula revenue up 801% year-on-year; cash burn A$328k in the quarterSales momentum
28–29 Aug 2025FY25 Annual Report: revenue A$7.17M (+14%); net loss A$5.26M (-29%); debt-free; cash A$2.69MResults
3 Sep 2025Chair buys 939,975 shares at up to A$0.045Insider buying
Sep 2025Vietnam sales suspended after a registration change; stock returns followRevenue setback
7 Oct 2025Chair buys 740k shares at up to A$0.042Insider buying
30 Oct 2025Q1 FY26 4C: revenue A$1.9M (+66% year-on-year); nutritional powders +1,239% year-on-year; cash A$1.9MGrowth confirmed
30 Oct 2025AGM: second strike; spill defeated (87.33% against); options and rights granted to CEO and chairGovernance
21 Jan 2026Q2 FY26 4C: revenue A$1.4M (-19% year-on-year, Vietnam returns); nutritional powders +152%; cash A$0.809MLiquidity tightens
22 Jan 2026Trading halt pending a capital raising; shares fall sharply (about A$0.027–0.029 to about A$0.017–0.019 per data providers)Funding signal
27 Jan 2026Non-renounceable entitlement offer at A$0.028 announcedEquity funding
18 Feb 2026Entitlement offer closes, leaving a shortfallWeak take-up
26 Feb 2026H1 FY26 interim: revenue A$3.20M (+14%); loss A$1.22M (-40%); nutritional powders revenue +431%; farm revenue -44%Profitability improving
Mar 2026Exhibits at the Vietbaby expo in VietnamMarket re-entry groundwork
30 Apr 2026Q3 FY26 4C: revenue A$1.4M; nutritional powders A$880k (+20% year-on-year)Slower quarter
15 May 2026Shortfall placement of 25M shares at A$0.028 (about A$0.7M); combined raise A$1.235MEquity funding
20 May 2026A$1.5M 12-month secured facility with RELI Capital (9.74% interest prepaid; loan-to-value cap 40%; secured on Yaringa)Debt funding
May 2026Sprout 12-month contract endsVolume headwind for FY27
29 May 2026RELI facility fully drawnNet-debt position
1 Jun 2026Ocean Dairy joint venture with Wellnex Life terminated; AHF takes 100%Simplification
6 Jul 2026Daniel Espie appointed independent director; Andy Zhang becomes GM – ChinaGovernance and China execution
Jul 2026Future™ shown at CBME ShanghaiBrand building
20 Jul 2026Chair Peter Nathan joins the Comvita board (NZX)External commitment (time-allocation monitorable)
31 Jul 2026Q4 FY26 4C: revenue A$2.6M (+90% quarter-on-quarter, -5% year-on-year); nutritional powders A$2.1M (+136% quarter-on-quarter); operating outflow A$1.4M; cash A$1.2MStrong quarter; continued burn
27 Aug 2026FY26 Annual Report: revenue A$7.15M (flat); loss A$2.79M (-47%); cash A$1.16M; material-uncertainty emphasis of matter; profitability guided to FY28Key results
Oct 2026 (expected)Q1 FY27 4C due by about 31 October; AGM expected about October/NovemberNext catalysts

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue fell from AUD 15.1 Mn in FY2022 to AUD 7.2 Mn in FY2026.
Australian Dairy Nutritionals Group — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue15.15.96.37.27.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.